Drugs Made In America Acquisition

Market cap

$264.133 M

$10.88 +0.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Drugs Made In America Acquisition (DMAA) has a market capitalization of $264.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$5.94M

#2143 by earnings

Shares outstanding

24,276,913

Latest filing cover page

P/E ratio

44.5

Cap ÷ net income

Other share classes

Drugs Made In America Acquisition lists more than one class of stock. Company figures above cover all classes combined.

DMAAR DMAAU

What if Drugs Made In America Acquisition were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,163,116

Per share 106,904× higher

Bitcoin $1.53T

$62,934.20

Per share 5,784× higher

Apple $5.02T

$206,607.10

Per share 18,990× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Drugs Made In America Acquisition are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.